Table 2.
MgSO4 indications | n/N (%) |
Pre-eclampsia | 46/63 (73) |
Neuroprotection | 38/63 (60) |
Pre-eclampsia and neuroprotection | 37/63 (59) |
None | 17/63 (27) |
Written protocol for indication and administration | 36/38 (95) |
Maximum gestational age | |
34 | 3/38 (8) |
33 | 7/38 (18) |
32 | 27/38 (71) |
31 | 0/38 (0) |
30 | 0/38 (0) |
29 | 0/38 (0) |
28 | 1/38 (3) |
MgSO4 regimen | |
Loading dose of 4 g then maintenance with 1 g/h for 12 h | 35/38 (92) |
Loading dose of 4 g then maintenance with 2 g/h for 12 h | 1/38 (3) |
Only maintenance with 1 g/h for 12 h | 2/38 (5) |
Repeat MgSO4 if birth does not occur after the first course of MgSO4 | 33/38 (87) |
Minimum interval between 2 treatments | |
< 24 h | 10/38 (26) |
24 to 48 h | 6/38 (16) |
> 48 h | 3/38 (8) |
Not specified by protocol | 19/38 (50) |
Maximum number of treatments | |
2 | 7/38(18) |
3 | 1/38 (3) |
No maximum number | 1/38 (3) |
Not specified by the protocol | 29/38 (76) |
Start of MgSO4 administration in the case of imminent delivery < 4 h (without delaying obstetric management) | 34/38 (90) |
Coprescription of calcium channel blockers | 33/38 (87) |
Values are n/N (%)
Percentages may not sum to 100 because of rounding